Skip to content

Si-Bone

US · SIBN #3357 by market cap Listed 2018
18.68 -0.42 -2.20%
Live - 5344 symbols - heartbeat 19s ago · 2026-10-08 10:10
Pre-market 19.10 0.00%
After-hours 19.10 0.00%
Market cap
837.21M
P/B
4.59
EPS
-0.44
Reader sentiment Are you bullish or bearish on SIBN?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Morgan Stanley Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $23
    Market Newswire · 2026/2/25
  • Rating change
    Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating
    Market Newswire · 2026/1/13
  • Rating change
    A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $22 to $27
    Market Newswire · 2026/2/24
  • Rating change
    BofA Securities Maintains Si-Bone(SIBN.US) With Buy Rating
    Market Newswire · 2026/5/13
  • Rating change
    Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $24
    Market Newswire · 2026/2/24
  • Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $21
    Market Newswire · 2026/7/16
  • A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $20 to $27
    Market Newswire · 2026/8/5
  • Rating change
    Piper Sandler Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $25
    Market Newswire · 2026/3/23
  • CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27
    Market Newswire · 2026/9/29
  • Rating change
    TD Cowen Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $21
    Market Newswire · 2026/1/27
  • Rating change
    Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18
    Market Newswire · 2026/5/12
  • Rating change
    Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $20
    Market Newswire · 2026/4/15
  • Rating change
    Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27
    Market Newswire · 2026/6/3
  • Rating change
    Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $18
    Market Newswire · 2026/5/12
  • Rating change
    TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $21
    Market Newswire · 2026/2/3
  • TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $20
    Market Newswire · 2026/8/4
  • TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $20
    Market Newswire · 2026/8/4
  • Rating change
    TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18
    Market Newswire · 2026/5/12
  • Rating change
    Jefferies Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $28
    Market Newswire · 2026/1/9
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Sight Sciences (SGHT) and SI-Bone (SIBN)
    TipRanks · 2026/1/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 10:10:53 · For reference only, not investment advice and not tailored to your situation.